Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human CTLA-4 (Research Grade Ipilimumab Biosimilar) Alexa Fluor 350-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Human Monoclonal Antibody

Supplier:  R&D Systems FAB9928U100UG

Catalog No. FAB9928U100


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

CTLA-4 Monoclonal specifically detects CTLA-4 in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

CTLA-4
Monoclonal
Alexa Fluor 350
Supplied 0.2 mg/ml in a saline solution containing BSA and Sodium Azide.
Human
Protein A or G purified from cell culture supernatant
Primary
Detects Human CTLA-4 based on Ipilimumab therapeutic antibody.This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. This product is for research use only.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
IgG1
Flow Cytometry
Hu111
Flow Cytometry 0.25-1 μg/10^6 cells
CD, CD152, CD152 antigen, CD152IDDM12, CD28, celiac disease 3, CELIAC3, CTLA4, CTLA-4, cytotoxic T-lymphocyte antigen 4, cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, cytotoxic T-lymphocyte-associated protein 4, cytotoxic T-lymphocyte-associated serine esterase-4, GRD4, GSE, ICOS, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
Human CTLA-4
100 μg
1493
Human
Supernatant
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.